Giant Mediastinal Mass in A 3-year-old Boy, A Rare Presentation of Neurofibromatosis Type I by karami, hossein et al.
109Iran J Child Neurol. Autumn 2021 Vol. 15 No. 4
Abstract
Neurofibromatosis type 1 (NF1) is an autosomal dominant disease 
diagnosed with the presentation of café-au-lait macules, skinfold 
freckling, iris Lisch nodules, neurofibromas, osseous lesion, and 
optic gliomas. Mediastinal mass as the first presentation of NF1 is 
very rare, with a frequency of about 2.7%. Here, we present a rare 
case of NF1 in a 3-year-old boy admitted with respiratory distress and 
superior vena cava syndrome.
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Introduction
Neurofibromatosis type 1 (NF1), or Von Recklinghausen disease, is 
an autosomal dominant disorder caused by mutation in the NF1 gene, 
located at chromosome 17 (1). This mutation results in diminished or 
loss of production of a protein named neurofibromin, causing clinical 
features of this disease (2).
The cardinal signs of this disease are café-au-lait spots, neurofibromas 
of any type, freckling in the axillae or groin, optic glioma, Lisch 
nodules, and dysplasia of the sphenoid or long bones. Also, familial 
history of NF1 in first-degree relatives is another central marker for 
diagnosis (3).
Orthopedic problems, including scoliosis, osteopenia, and 
osteoporosis, hypertension, precocious puberty, learning disabilities, 
such as attention deficit hyperactivity disorder (ADHD), and seldom 
seizure are the rare presentations or complications of this disease (4). 
In less than 3% of cases, the disease appears as a primary mediastinal 
mass (5). Here, we describe a case of NF1 presented by huge 
mediastinal mass and respiratory distress.
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Case Report
A 3-year-old boy was admitted with severe 
respiratory distress and tachypnea after upper 
respiratory tract infection. He had dyspnea, cough, 
orthopnea, respiratory rate about 43 /min, and mild 
plethora of the face.
He was the only child of family, and his parents 
were not relatives. He was born through normal 
vaginal delivery, and his Apgar score was 10 at birth 
and 5 minutes after birth. He had no developmental 
delay, but his weight and height were under 3 
percentiles of growth, which was also evident on 
physical examination. We did not find significant 
data in his past medical history.
On physical examination, we found a 5 x 4 cm 
mass on the left supraclavicular area and neck. The 
mass was firm and non-tender. Blood pressure was 
normal. Skin examination revealed multiple café-
au-lait spots (Figures 1-A, 1-B, & 1-C).
Laboratory data showed hemoglobin (Hb) 10.9 g/
dL, WBC 13300 /µL, neutrophil 29%, eosinophil 
7%, monocyte 8%, lymphocyte 56%, platelet count 
262000/µL, urea 21mg/dL, creatinine 0.6 mg/dL, 
uric acid 3.9 mg/dL, and lactate dehydrogenase 
(LDH) 754 U/L. Beta-HCG was 0.66 m IU/ml and 
alpha fetoprotein was 1.01 IU/ml.
Chest radiograph was obtained, which showed a 
large mediastinal mass (Figure 2-A), and chest 
CT scan revealed a heterogenous mass on the left 
mediastinum (Figure 2-B) with extension from 
thoracic inlet to the neck (Figure 2-C). The mass 
compressed the neck vessels and airway.
Corticosteroids were started because of respiratory 
distress and superior vena cava syndrome. After 
three days, the patient became stable, and incisional 
biopsy was taken from the neck mass, indicating 
proliferation of spindle cells within wire-like 
collagen fibrils in loose background, in favor of 
neurofibromatosis (Figure 3).
Figure 1. multiple café-au-lait spots on the skin 
of trunk (1-A), face (1-B), and thigh (1-C)
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Discussion
Neurofibromatosis type 1 (NF1) is an autosomal 
dominant disease and about one-half of cases are 
familial (6). The disease is clinically diagnosed with 
the presentation of café-au-lait macules, skinfold 
freckling, iris Lisch nodules, neurofibromas, 
osseous lesion, and optic gliomas (7). However, 
all features may not be present in all patients. 
Mediastinal mass as the first presentation of NF1 
is very rare, with a frequency of about 2.7% (5).
Intrathoracic neurofibromatosis mostly arises from 
ganglia or nerves of sympathetic trunk and rarely 
from the trachea or esophagus (8, 9). Mediastinal 
neurofibromas can transform into malignant 
peripheral nerve sheath tumors (MPNST) (10).
Symptoms and signs of mediastinal 
neurofibromatosis vary by location, tumor size, 
and tumor extension to other organs. Superior vena 
cava syndrome may result due to the impairment of 
venous return. Dyspnea is a presentation of airway 
compression or may results from phrenic nerve 
involvements and hemidiaphragm paralysis (8).
The first imaging modality, chest radiography, 
shows a homogenous or heterogenous mass, and 
computed tomography scan technique may detect 
more details. Magnetic resonance imaging (MRI) 
in neurofibromatosis type 1 shows areas of T2 
hyperintensity, and it seems to be more useful for 
the diagnosis of NF1-related malignant tumors 
(11). A sensitivity of 100% and specificity of 77-
95% have made PET/CT a superior diagnostic tool 
for detecting malignant transformation in NF1 (12). 
Figure 2. A large mediastinal mass in chest X-ray (2-A) and a heterogenous mass in chest CT scan of thoraces (2-B) with extension to neck (2-C)
Figure 3. Histologic examination shows spindle cells within wire-like 
collagen fibrils
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Elongated spindle-shaped cells and pleomorphic 
fibroblast-like cells are the main histologic 
findings in NF1 (13). Molecular testing is now 
available for the diagnosis of NF1, but it is not 
routinely indicated for clinical care, especially 
because of less genotype-phenotype correlations 
(14, 15). Nevertheless, it may be helpful and is 
recommended in young children with multiple 
café-au-lait spots only and no family history (16).
Finally, other differential diagnoses must be 
considered in any patient with signs and symptoms 
similar to NF1, like NF1-like syndrome, familial 
café-au lait spots (FCALS), and segmental NF1 
(17). Our patient was a rare case of mediastinal 
NF1, which presented by respiratory distress and 
superior vena cava syndrome. Base on clinical 
manifestations and histologic findings, our 
patient was rapidly referred to a thoracic surgeon. 
Surgery is the main treatment approach, and it is 
recommended that surgery be performed in one 
step (18).
In Conclusion
Despite the rarity of NF1 as a mediastinal mass, 
this diagnosis should be considered as a differential 
diagnosis, especially when one or more other signs 
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